Revanesse
- Company typePrivate
- Founded2002
- HeadquartersAurora, Canada
- Headcount101–250
- GTM typeB2B
- OfferingHardware or Manufacturing
Revanesse firmographics
Firmographics- Name
- Revanesse
- Website
- https://revanesse.com
- Company type
- Private
- Founded year
- 2002
- Headcount range
- 101–250 employees
- Ownership category
- akta.pro rank
Revanesse industry classification
Industry- Product category
- Medical Aesthetics
- NAICS
- Pharmaceutical Preparation Manufacturing (325412)
- SIC
- Pharmaceutical Preparations (2834)
- akta.pro primary industry
- Dermatology & Aesthetics Pharmaceuticals (HLAIAAAK)
Keywords
Where Revanesse is headquartered
LocationHeadquarters
- HQ city
- Aurora
- HQ country
- Canada
- HQ region
- North America
Markets served
Revanesse business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Personnel, Supply Chain, Operations, Technology or R&D, Marketing or Sales, Infrastructure
Revanesse product offering
Product offeringCore offering
Revanesse is a pharmaceutical company that researches and manufactures aesthetic and medical products, operating in the medical aesthetics space. The company develops injectable and related products intended for use by medical professionals in the aesthetic and dermatological treatment market.
Product overview
No product information is available in the source data. The Revanesse website (http://revanesse.com/) displayed a loading/verification page stating "One moment, please..." with no accessible content about the company's products, services, or overall offering.
Differentiator
Problem solved
Functional benefit
Companies that use Revanesse
Customer profileIdeal customer profiles1 record
Revanesse technology and API
TechnologyAPI detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Revanesse competitors and assessment
Company assessmentDirect peers
- Galderma: Global aesthetics leader and one of the largest hyaluronic acid dermal filler manufacturers (Restylane, Sculptra). Directly comparable to Revanesse on product category (HA fillers) and target customer (aesthetic injectors and dermatologists).
- Merz Aesthetics: Specialty aesthetics business selling HA fillers (Belotero) and biostimulators (Radiesse) to the same injector base. Direct competitor in the dermatology and aesthetics injectables market.
- Prollenium Medical Technologies: Canadian-based HA dermal filler manufacturer (Revofil, Aquashine) selling into North America and international markets. Closest geographic and product-line comparable to Revanesse.
- Teoxane Laboratories: Swiss manufacturer of HA dermal fillers (Teosyal) serving aesthetic practitioners globally. Direct peer in branded HA fillers with a similar specialty-pharma go-to-market.
- Croma-Pharma: Austrian specialty aesthetics company producing HA fillers, PRP kits, and ophthalmology products. Comparable mid-sized specialty aesthetics manufacturer competing for injector share.
- Sinclair Pharma (Huons): Specialty aesthetics company with HA fillers (MaiLi) and collagen stimulators (Ellansé). Now under Huons Group; targets the same aesthetic clinics as Revanesse in Europe and select international markets.
- Evolus: US aesthetics pure-play behind Jeuveau (botulinum toxin), competing for the same non-surgical aesthetics accounts and physician relationships as Revanesse, though focused on neurotoxins rather than fillers.
- Hugel (Aesthetics division): Korean specialty aesthetics/biopharma company with botulinum toxin (Botulax) and HA fillers sold internationally. Comparable specialty aesthetics manufacturer pursuing global clinic relationships.
Broad incumbents
- AbbVie (Allergan Aesthetics): Owner of the Juvederm filler franchise and Botox — the dominant incumbent in aesthetics. Overlaps with Revanesse in HA fillers and competes for the same clinic accounts, though at much greater scale.
- Ipsen (Dysport / aesthetics): Global biopharma with a significant aesthetics franchise in Dysport/aesthetic botulinum toxin and adjacent injectable treatments. Larger incumbent with overlapping channels and customer overlap with Revanesse.
Market position
Strengths4 records
Weaknesses4 records
Competitive moat2 records
Key risks3 records
Key highlights4 records
Customer concentration
Revanesse financial estimates
Financial estimateRevenue estimate
Valuation estimate
Revanesse leadership team
Management profileNumber of profiles
Revanesse funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Revanesse M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Revanesse
What does Revanesse do?
Revanesse is a pharmaceutical company that researches and manufactures aesthetic and medical products, operating in the medical aesthetics space. The company develops injectable and related products intended for use by medical professionals in the aesthetic and dermatological treatment market.
When was Revanesse founded?
Revanesse was founded in 2002. It employs 101 to 250 people.
Where is Revanesse based?
Revanesse is headquartered in Aurora, Canada, in the North America region.
Who are Revanesse's main competitors?
Direct peers on record are Galderma, Merz Aesthetics, Prollenium Medical Technologies, Teoxane Laboratories, Croma-Pharma, Sinclair Pharma (Huons), Evolus and Hugel (Aesthetics division). Broad incumbents are AbbVie (Allergan Aesthetics) and Ipsen (Dysport / aesthetics).
Does Revanesse have an API?
No public API is recorded for Revanesse.
What industry is Revanesse in?
Revanesse's product category is Medical Aesthetics. Its primary akta.pro industry code is HLAIAAAK, Dermatology & Aesthetics Pharmaceuticals. Its NAICS code is 325412 and its SIC code is 2834.